ErbB and HB-EGF signaling in heart development and function

Cell Structure and Function

Volumn 31, Issue 1, 2006, Pages 1-14

  Iwamoto, Ryo ^a   Mekada, Eisuke ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Cardiac cushion; Ectodomain shedding; Gene targeting; Myocardium; Valve remodeling; Valvulogenesis

Indexed keywords

EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; PROTEIN TYROSINE KINASE;

CELL DIFFERENTIATION; CELL PROLIFERATION; HEART DEVELOPMENT; HEART FUNCTION; HEART VALVE; HOMEOSTASIS; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VERTEBRATE; ANIMAL; CLASSIFICATION; HEART; HEART MUSCLE; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MAMMALIA; VERTEBRATA;

ANIMALS; EPIDERMAL GROWTH FACTOR; HEART; HUMANS; MYOCARDIUM; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 33646140934     PISSN: 03867196     EISSN: 13473700     Source Type: Journal    
DOI: 10.1247/csf.31.1     Document Type: Review

References (110)

1. Armstrong, E.J. and Bischoff, J. 2004. Heart valve development: endothelial cell signaling and differentiation. Circ. Res., 95: 459-470.
2. Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H., Asanuma, H., Sanada, S., Matsumura, Y., Takeda, H., Beppu, S., Tada, M., Hori, M., and Higashiyama, S. 2002. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med., 8: 35-40.
3. Aviezer, D. and Yayon, A. 1994. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc. Natl. Acad. Sci. USA, 91: 12173-12177.
4. Britto, J.M., Lukehurst, S., Weller, R., Fraser, C., Qiu, Y., Hertzog, P., and Busfield, S.J. 2004. Generation and characterization of neuregulin-2-deficient mice. Mol. Cell. Biol., 24: 8221-8226.
5. Brutsaert, D.L. 2003. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev., 83: 59-115.
6. Camenisch, T.D., Spicer, A.P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M.L., Calabro, A. Jr., Kubalak, S., Klewer, S.E., and McDonald, J.A. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest., 106: 349-360.
7. Camenisch, T.D., Schroeder, J.A., Bradley, J., Klewer, S.E., and McDonald, J.A. 2002. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat. Med., 8: 850-855.
8. Chang, C.P., Neilson, J.R., Bayle, J.H., Gestwicki, J.E., Kuo, A., Stankunas, K., Graef, I.A., and Crabtree, G.R. 2004. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell, 118: 649-663.
9. Chen, B., Bronson, R.T., Klaman, L.D., Hampton, T.G., Wang, J.F., Green, P.J., Magnuson, T., Douglas, P.S., Morgan, J.P., and Neel, B.C. 2000. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat. Genet., 24: 296-299.
10. Chien, K.R. 2000. Myocyte survival pathways and cardiomyopathy: implications for trastuzumab cardiotoxicity. Semin. Oncol., 27: 9-14.
11. Chien, K.R. and Olson, E.N. 2002. Converging pathways and principles in heart development and disease: CV@CSH. Cell, 110: 153-162.
12. Clark, T.G., Conway, S.J., Scott, I.C., Labosky, P.A., Winnier, G., Bundy, J., Hogan, B.L., and Greenspan, D.S. 1999. The mammalian Tolloid-like 1 gene, T111, is necessary for normal septation and positioning of the heart. Development, 126: 2631-2642.
13. Crackower, M.A., Oudit, G.Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Hirsch, E., Suzuki, A., Shioi, T., Irie-Sasaki, J., Sah, R., Cheng, H.Y., Rybin, V.O., Lembo, G., Fratta, L., Oliveira-dos-Santos, A.J., Benovic, J.L., Kahn, C.R., Izumo, S., Steinberg, S.F., Wymann, M.P., Backx, P.H., and Penninger, J.M. 2002. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell, 110: 737-749.
14. Crone, S.A., Zhao, Y.Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K.L., Chen, J., Kahn, R., Condorelli, G., Ross, J. Jr., Chien, K.R., and Lee, K.F. 2002. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat. Med., 8: 459-465.
15. Crone, S.A., Negro, A., Trumpp, A., Giovannini, M., and Lee, K.F. 2003. Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous system. Neuron, 37: 29-40.
16. Das, S.K., Wang, X.N., Paria, B.C., Damm, D., Abraham, J.A., Klagsbrun, M., Andrews, O.K., and Dey, S.K. 1994. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development, 120: 1071-1083.
17. Delot, E.C., Bahamonde, M.E., Zhao, M., and Lyons, K.M. 2003. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development, 130: 209-220.
18. Di Fiore, P.P., Segatto, O., Taylor, W.O., Aaronson, S.A., and Pierce, J.H. 1990. EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science, 248: 79-83.
19. Eguchi, S., Dempsey, P.J., Frank, G.D., Motley, E.D., and Inagami, T. 2001. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J. Biol. Chem., 276: 7957-7962.
20. Eisenberg, L.M. and Markwald, R.R. 1995. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res., 77: 1-6.
21. Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M. 1997. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J., 16: 1268-1278.
22. Emanueli, C., Maestri, R., Corradi, D., Marchione, R., Minasi, A., Tozzi, M.G., Salis, M.B., Straino, S., Capogrossi, M.C., Olivetti, G., and Madeddu, P. 1999. Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice. Circulation, 100: 2359-2365.
23. Erickson, S.L., O'Shea, K.S., Ghaboosi, N., Loverro, L., Frantz, G., Bauer, M., Lu, L.H., and Moore, M.W. 1997. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice. Development, 124: 4999-5011.
24. 2+/calmodulin-dependent kinase II phosphorylates the epidermal growth factor receptor on multiple sites in the cytoplasmic tail and serin 744 within the kinase domain to regulate signal generation. J. Biol. Chem., 274: 16168-16173.
25. Fu, S., Bottoli, I., Goller, M., and Vogt, P.K. 1999. Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. Proc. Natl. Acad. Sci. USA, 96: 5716-5721.
26. Galvin, K.M., Donovan, M.J., Lynch, C.A., Meyer, R.I., Paul, R.J., Lorenz, J.N., Fairchild-Huntress, V., Dixon, K.L., Dunmore, J.H., Gimbrone, M.A. Jr., Falb, D., and Huszar, D. 2000. A role for smad6 in development and homeostasis of the cardiovascular system. Nat. Genet., 24: 171-174.
27. Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., and Lemke, G. 1995. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature, 378: 390-394.
28. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E., and Taniguchi, N. 1995. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell, 6: 967-980.
29. Goishi, K., Lee, P., Davidson, A.J., Nishi, E., Zon, L.I., and Klagsbrun, M. 2003. Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects. Mech. Dev., 120: 811-822.
30. Golub, M.S., Germann, S.L., and Lloyd, K.C. 2004. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav. Brain Res., 153: 159-170.
31. Graus-Porta, D., Beerli, R.R., Daly, J.M., and Hynes, N.B. 1997. ErbB-2, the preferred heterodimerization partner of all ErbB receptor, is a mediator of lateral signaling. EMBO J., 16: 1647-1655.
32. Guy, P.M., Platko, J.V., Cantley, L.C., Cerione, R.A., and Carraway, K.L. 3rd. 1994. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA, 91: 8132-8136.
33. Higashiyama, S., Abraham, J.A., Miller, J., Fiddes, J.C., and Klagsbrun, M. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science, 251: 936-939.
34. Higashiyama, S., Lau, K., Besner, G.E., Abraham, J.A., and Klagsbrun, M. 1992. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem., 267: 6205-6212.
35. Higashiyama, S., Abraham, J.A., and Klagsbrun, M. 1993. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol., 122: 933-940.
36. Higashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M., and Mekada, E. 1995. The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell Biol., 128: 929-938.
37. Hilborn, M.D., Vaillancourt, R.R., and Rane, S.G. 1998. Growth factor receptor tyrosine kinases acutely regulate neuronal sodium channels through the src signaling pathway. J. Neurosci., 18: 590-600.
38. Hirota, H., Chen, J., Betz, U.A., Rajewsky, K., Gu, Y., Ross, J. Jr., Muller, W., and Chien, K.R. 1999. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell, 97: 189-198.
39. Holbro, T., Civenni, G., and Hynes, N.E. 2003. The ErbB receptors and their role in cancer progression. Exp. Cell Res., 284: 99-110.
40. Horan, T., Wen, J., Arakawa, T., Liu, N., Brankow, D., Hu, S., Ratzkin, B., and Philo, J.S. 1995. Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3. J. Biol. Chem., 270: 24604-24608.
41. Hurlstone, A.F., Haramis, A.P., Wienholds, E., Begthel, H., Korving, J., Van Eeden, F., Cuppen, E., Zivkovic, D., Plasterk, R.H., and Clevers, H. 2003. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature, 425: 633-637.
42. Iwamoto, R., Higashiyama, S., Mitamura, T., Taniguchi, N., Klagsbrun, M., and Mekada, E. 1994. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J., 13: 2322-2330.
43. Iwamoto, R., Handa, K., and Mekada, E. 1999. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol. Chem., 274: 25906-25912.
44. Iwamoto, R. and Mekada, E. 2000. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev., 11: 335-344.
45. Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G., Nanba, D., Higashiyama, S., Hori, M., Klagsbrun, M., and Mekada, E. 2003. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA, 100: 3221-3226.
46. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S., and Mekada, E. 1998. A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J., 17: 7260-7272.
47. Jackson, L.F., Qiu, T.H., Sunnarborg, S.W., Chang, A., Zhang, C., Patterson, C., and Lee, B.C. 2003. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J., 22: 2704-2716.
48. Kim, H.H., Vijapurkar, U., Hellyer, N.J., Bravo, D., and Koland, J.G. 1998. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein. Biochem. J., 334: 189-195.
49. Kim, R.Y., Robertson, E.J., and Solloway, M.J. 2001. Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev. Biol., 235: 449-466.
50. Kimura, R., Iwamoto, R., and Mekada, E. 2005. Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia. Cell Struct. Fund., 30: 35-42.
51. Kretzschmar, M., Doody, J., and Massague, J. 1997. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1.Nature, 389: 618-622.
52. Kurisaki, T., Masuda, A., Sudo, K., Sakagami, J., Higashiyama, S., Matsuda, Y., Nagabukuro, A., Tsuji, A., Nabeshima, Y., Asano, M., Iwakura, Y., and Sehara-Fujisawa, A. 2003. Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol. Cell Biol., 23: 55-61.
53. Lakkis, M.M. and Epstein, J.A. 1998. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development, 125: 4359-4367.
54. Lamers, W.H., Viragh, S., Wessels, A., Moorman, A.F., and Anderson, R.H. 1995. Formation of the tricuspid valve in the human heart. Circulation, 91: 111-121.
55. Lee, K.F., Simon, H., Chen, H., Bates, B., Hung, M.C., and Hauser, C. 1995. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature, 378: 394-398.
56. Lemjabbar, H. and Basbaum, C. 2002. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med., 8: 41-46.
57. Lo, R.S., Wotton, D., and Massague, J. 2001. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J., 20: 128-136.
58. Long, W., Wagner, K.U., Lloyd, K.C., Binart, N., Shillingford, J.M., Hennighausen, L., and Jones, F.E. 2003. Impaired differentiation and lactational failure of ErbB4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development, 130: 5257-5268.
59. Luetteke, N.C., Qiu, T.H., Peiffer, R.L., Oliver, P., Smithies, O., and Lee, D.C. 1993. TGF α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell, 73: 263-278.
60. Luetteke, N.C., Qiu, T.H., Fenton, S.E., Troyer, K.L., Riedel, R.F., Chang, A., and Lee, D.C. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development, 126: 2739-2750.
61. Mann, G.B., Fowler, K.J., Gabriel, A., Nice, B.C., Williams, R.L., and Dunn, A.R. 1993. Mice with a null mutation of the TGF α gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell, 73: 249-261.
62. Marikovsky, M., Breuing, K., Liu, P.Y., Eriksson, E., Higashiyama, S., Farber, P., Abraham, J., and Klagsbrun, M. 1993. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad Sci. USA, 90: 3889-3893.
63. Massague, J. and Pandiella, A. 1993. Membrane-anchored growth factors. Annu. Rev. Biochem., 62: 515-541.
64. Meier, T., Masciulli, F., Moore, C., Schoumacher, F., Eppenberger, U., Denzer, A.J., Jones, G., and Brenner, H.R. 1998. Agrin can mediate acetylcholine receptor gene expression in muscle by aggregation of muscle-derived neuregulins. J. Cell Biol., 141: 715-726.
65. Meyer, D. and Birchmeier, C. 1995. Multiple essential functions of neuregulin in development. Nature, 378: 386-390.
66. Miettinen, P.J., Berger, J.E., Meneses, J., Phung, Y., Pedersen, R.A., Werb, Z., and Derynck, R. 1995. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature, 376: 337-341.
67. Mine, N., Iwamoto, R., and Mekada, E. 2005. HB-EGF promotes epithelial cell migration in eyelid development. Development, 132: 4317-4326.
68. Miyagawa, J., Higashiyama, S., Kawata, S., Inui, Y., Tamura, S., Yamamoto, K., Nishida, M., Nakamura, T., Yamashita, S., Matsuzawa, Y., and Taniguchi, N. 1995. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest., 95: 404-411.
69. Miyamoto, S., Hirata, M., Yamazaki, A., Kageyama, T., Hasuwa, H., Mizushima, H., Tanaka, Y., Yagi, H., Sonoda, K., Kai, M., Kanoh, H., Nakano, H., and Mekada, E. 2004. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res., 64: 5720-5727.
70. Morris, J.K., Lin, W., Hauser, C., Marchuk, Y., Getman, D., and Lee, K.F. 1999. Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development. Neuron, 23: 273-283.
71. Naglich, J.G., Metherall, J.E., Russell, D.W., and Eidels, L. 1992. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell, 69: 1051-1061.
72. Nakajima, Y., Yamagishi, T., Hokari, S., and Nakamura, H. 2000. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat. Rec., 258: 119-127.
73. Nakamura, K., Iwamoto, R., and Mekada, E. 1995. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin α3β1 at cell-cell contact sites. J. Cell Biol., 129: 1691-1705.
74. Nebigil, C.G., Hickel, P., Messaddeq, N., Vonesch, J.L., Douchet, M.P., Monassier, L., Gyorgy, K., Matz, R., Andriantsitohaina, R., Manivet, P., Launay, J.M., and Maroteaux, L. 2001. Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation, 103: 2973-2979.
75. Nishi, E., Prat, A., Hospital, V., Elenius, K., and Klagsbrun, M. 2001. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J., 20: 3342-3350.
76. Nonaka, K., Shum, L., Takahashi, I., Takahashi, K., Ikura, T., Dashner, R., Nuckolls, G.H., and Slavkin, H.C. 1999. Convergence of the BMP and EGF signaling pathways on Smad1 in the regulation of chondrogenesis. Int. J. Dev. Biol., 43: 795-807.
77. Olayioye, M.A., Neve, R.M., Lane, H.A., and Hynes, N.E. 2000. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J., 19: 3159-3167.
78. Ozcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hubner, N., Chien, K.R., Birchmeier, C., and Garratt, A.N. 2002. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc. Natl. Acad Sci. USA, 99: 8880-8885.
79. Powell, P.P., Klagsbrun, M., Abraham, J.A., and Jones, R.C. 1993. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol., 143: 784-793.
80. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., and Ullrich, A. 1999. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature, 402: 884-888.
81. Raab, G. and Klagsbrun, M. 1997. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta, 1333: F179-F199.
82. nd. and Stern, D.F. 1998. Specificity within the EGF family/ErbB receptor family signaling network. BioEssays, 20: 41-48.
83. Riethmacher, D., Sonnenberg-Riethmacher, E., Brinkmann, V., Yamaai, T., Lewin, G.R., and Birchmeier, C. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature, 389: 725-730.
84. Sahin, U., Weskamp, G., Kelly, K., Zhou, H.M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P., and Blobel, C.P. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol., 164: 769-779.
85. Schroeder, J.A., Jackson, L.F., Lee, D.C., and Camenisch, T.D. 2003. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J. Mol. Med., 81: 392-403.
86. Seidman, J.G. and Seidman, C. 2001. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell, 104: 557-567.
87. Sibilia, M. and Wagner, E.F. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science, 269: 234-238.
88. Shirakata, Y., Kimura, R., Nanba, D., Iwamoto, R., Tokumaru, S., Morimoto, C., Yokota, K., Nakamura, M., Sayama, K., Mekada, E., Higashiyama, S., and Hashimoto, K. 2005. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J. Cell Sci., 118: 2363-2370.
89. Shirasawa, S., Sugiyama, S., Baba, I., Inokuchi, J., Sekine, S., Ogino, K., Kawamura, Y., Dohi, T., Fujimoto, M., and Sasazuki, T. 2004. Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage. Proc. Natl. Acad. Sci. USA, 101: 13921-13926.
90. Shishido, Y., Sharma, K.D., Higashiyama, S., Klagsbrun, M., and Mekada, E. 1995. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem., 270: 29578-29585.
91. Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J., and Norton, L. 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med., 344: 783-792.
92. Sugi, Y., Ito, N., Szebenyi, G., Myers, K., Fallon, J.F., Mikawa, T., and Markwald, R.R. 2003. Fibrobrast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev. Biol., 258: 252-263.
93. Takazaki, R., Shishido, Y., Iwamoto, R., and Mekada, E. 2004. Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like growth factor. J. Biol. Chem., 279: 47335-47343.
94. Takemura, T., Hino, S., Kuwajima, H., Yanagida, H., Okada, M., Nagata, M., Sasaki, S., Barasch, J., Harris, R.C., and Yoshioka, K. 2001. Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J. Am. Soc. Nephrol., 12: 964-972.
95. Takenobu, H., Yamazaki, A., Hirata, M., Umata, T., and Mekada, E. 2003. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate-and lysophosphatidic acid-induced signaling cascade. J. Biol. Chem., 278: 17255-17262.
96. Threadgill, D.W., Dlugosz, A.A., Hansen, L.A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R.C., Barnard, J.A., Yuspa, S.H., Coffey, R.J., and Magnuson, T. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science, 269: 230-234.
97. Tidcombe, H., Jackson-Fisher, A., Mathers, K., Stern, D.F., Gassmann, M., and Golding, J.P. 2003. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad Sci. USA, 100: 8281-8286.
98. Timmerman, L.A., Grego-Bessa, J., Raya, A., Bertran, E., Perez-Pomares, J.M., Diez, J., Aranda, S., Palomo, S., McCormick, F., Izpisua-Belmonte, J.C., and de la Pompa, J.L. 2004. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev., 18: 99-115.
99. Tokumaru, S., Higashiyama, S., Endo, T., Nakagawa, T., Miyagawa, J.I., Yamamori, K., Hanakawa, Y., Ohmoto, H., Yoshino, K., Shirakata, Y., Matsuzawa, Y., Hashimoto, K., and Taniguchi, N. 2000. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol., 151: 209-220.
100. Towbin, J.A. and Bowles, N.B. 2002. The failing heart. Nature, 415: 227-233.
101. Troyer, K.L., Luetteke, N.C., Saxon, M.L., Qiu, T.H., Xian, C.J., and Lee, D.C. 2001. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-α. Gastroenterology, 121: 68-78.
102. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J., and Yarden, Y. 1996. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell Biol., 16: 5276-5287.
103. Umata, T., Hirata, M., Takahashi, T., Ryu, F., Shida, S., Takahashi, Y., Tsuneoka, M., Miura, Y., Masuda, M., Horiguchi, Y., and Mekada, E. 2001. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem., 276: 30475-30482.
104. Wenink, A.C. and Gittenberger-de Groot, A.C. 1986. Embryology of the mitral valve. Int. J. Cardiol., 11: 75-84.
105. Wischmeyer, E., Doring, F., and Karschin, A. 1998. Acute suppression of inwardly rectifying Kir2.1 channels by direct tyrosine kinase phosphorylation. J. Biol. Chem., 273: 34063-34068.
106. Yamazaki, S., Iwamoto, R., Saeki, K., Asakura, M., Takashima, S., Yamazaki, A., Kimura, R., Mizushima, H., Moribe, H., Higashiyama, S., Endoh, M., Kaneda, Y., Takagi, S., Itami, S., Takeda, N., Yamada, G., and Mekada, E. 2003. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell Biol., 163: 469-475.
107. Yarden, Y. 2001. The EGFR family and its ligands in human cancer, signalling mechanisms and therapeutic opportunities. Eur. J. Cancer, 37: S3-S8.
108. Yarden, Y. and Sliwkowski, M.X. 2001. Untangling the ErbB signaling network. Nat. Rev. Mol. Cell. Biol., 2: 127-137.
109. Yussman, M.G., Toyokawa, T., Odley, A., Lynch, R.A., Wu, G., Colbert, M.C., Aronow, B.J., Lorenz, J.N., and Dorn, G.W. 2nd. 2002. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat. Med., 8: 725-730.
110. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J. Biol. Chem., 277: 1261-1267.